Based on these observations, Fang et al. [5] hypothesized that the use of ACE inhibitors or angiotensin 2 receptor blockers in hypertensive patients infected with SARS-COV-2 virus and symptoms characteristic of COVID-19 may be dangerous (even harmful). Here, AGTR2 is linked to COVID-19.